Atlas Trials

Exploring Brain Molecular Imaging and Blood Biomarkers in Subjects With Glucocerebrosidase Mutations: Toward a Precision Medicine Approach to Characterize Parkinson's Disease Clinical Trajectories

Clinical trial NCT06167603 · UNKNOWN

Trial details

NCT number
NCT06167603
Sponsor
IRCCS San Raffaele
Status
UNKNOWN
Study type
OBSERVATIONAL
Parkinson Disease
Start date
2023-04-30
Primary completion
2024-12-12
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.